Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Return on Capital Employed (2024 - 2025)

Historic Return on Capital Employed for Zenas BioPharma (ZBIO) over the last 2 years, with Q3 2025 value amounting to 0.79%.

  • Zenas BioPharma's Return on Capital Employed changed N/A to 0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79%, marking a year-over-year change of. This contributed to the annual value of 1.01% for FY2024, which is N/A changed from last year.
  • Per Zenas BioPharma's latest filing, its Return on Capital Employed stood at 0.79% for Q3 2025.
  • In the past 5 years, Zenas BioPharma's Return on Capital Employed registered a high of 0.5% during Q4 2024, and its lowest value of 0.79% during Q3 2025.